Quick Answer
Orchestra BioMed Holdings, Inc. reported Shares Outstanding of 57.03 million shares for fiscal year 2025.
Orchestra BioMed Holdings, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 57.03M | +49.3% |
| 2024 | 38.19M | +6.8% |
| 2023 | 35.78M | +77.2% |
| 2022 | 20.19M | +353.7% |
| 2021 | 4.45M | +0.0% |
| 2020 | 4.45M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 56.46M | +48.8% | +46.1% |
| June 30, 2025 | 38.64M | +7.9% | +0.9% |
| March 31, 2025 | 38.31M | +7.1% | +0.3% |
| December 31, 2024 | 38.19M | +6.8% | +0.7% |
| September 30, 2024 | 37.94M | +6.2% | +5.9% |
| June 30, 2024 | 35.82M | +0.2% | +0.1% |
| March 31, 2024 | 35.78M | +12.7% | +0.0% |
| December 31, 2023 | 35.78M | +77.2% | +0.1% |
- Orchestra BioMed Holdings, Inc. showed an increase of +49.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Orchestra BioMed Holdings, Inc.’s shares outstanding has grown by 1181.6% (from 4.45 million shares to 57.03 million shares).
- The most recent figure is from Orchestra BioMed Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: